JPRN-UMIN000003653已完成2 期
Phase II study of S-1 plus amrubicin as the 2nd-line treatment for non-small cell lung cancer without EGFR mutation - Phase II study of S-1 plus amrubicin as the 2nd-line treatment for non-small cell lung cancer without EGFR mutation
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •1)patients previously treated with amrubicin and 5-FU derivative drugs 2)pleural effusion(eligible for difficult puncture case or cytologically negative and clinically ignorable case) 3)evident pericardial effusion 4)serious complications below uncontrollable angina pectoris, myocardial infarction within 3 months or heart failure uncontrollable diabetes uncontrollable hypertension severe infection 5)pulmonary fibrosis or interstitial pneumonitis evident 6)HB and HC virus carrier 7)now pregnant or lactation 8)difficult to perform or continue of this study
研究者
相似试验
已完成
2 期
A phase II study of amrubicin for previously treated small cell lung cancerFor patients with recurrent small cell lung cancerJPRN-UMIN000001752Gunma University Hospital35
已完成
2 期
Phase II study of amrubicin for previously treated advanced non-small cell lung cancerRecurrent non-small cell lung cancerJPRN-UMIN000001751Gunma University Hospital35
已完成
1 期
PhaseI Study of Amrubicin for Previously Treated Small Cell Lung CancerFor patients with recurrent or relapsed small cell lung cancerJPRN-C000000177Kobe City General Hospital18
已完成
不适用
Phase II Study of Amrubicin in Patients with Non-Small Cell Lung Cancer Previously Treated with Platinum-Based ChemotherapyAll patients had histologocally or cytologically confirmed locally advanced (non-irradiated) or metastatic NSCLC, with failure of platinum-based chemotherapy (exception for UFT and gefitinib).JPRN-C000000071West Japan Oncology Group60
已完成
不适用
Phase 2 study of amrubicin in previously treated patients with malignant pleural mesotheliomaMalignant pleural mesotheliomaJPRN-UMIN000006381agasaki University Hospital32
